Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension
Neurology® Nov 07, 2017
Gracies JM, et al. - Authors aspired to illustrate single abobotulinumtoxinA injection efficacy in lower limb vs placebo for adults with chronic hemiparesis. Additionally, they gauged the long-term safety and efficacy of repeated injections. The administration of single abobotulinumtoxinA (Dysport Ipsen) reduced muscle tone in the case of chronic hemiparesis. Repeated administration over a year appeared to be well-tolerated and resulted in improved walking speed and the tendency of achieving community ambulation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries